KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis

Cancer Cell

Volumn 29, Issue 3, 2016, Pages 324-338

  Wei, Daoyan ^a   Wang, Liang ^a   Yan, Yongmin ^a   Jia, Zhiliang ^a   Gagea, Mihai ^a   Li, Zhiwei ^a   Zuo, Xiangsheng ^a   Kong, Xiangyu ^a   Huang, Suyun ^a   Xie, Keping ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DAMAGE; CELL STRESS; CELL TRANSFORMATION; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; METAPLASIA; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PANCREAS INJURY; PANCREATIC CARCINOGENESIS; PANCREATIC TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UPREGULATION; ANIMAL; GENETICS; METABOLISM; ONCOGENE RAS; PANCREAS; PANCREAS CARCINOMA; PANCREATIC DUCT; PATHOLOGY; PRECANCER; TUMOR CELL LINE;

ACINAR CELLS; ANIMALS; CARCINOGENESIS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; PANCREAS; PANCREATIC DUCTS; PRECANCEROUS CONDITIONS; UP-REGULATION;

EID: 84962826169     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.02.005     Document Type: Article

References (61)

1. Abrigo M., Alvarez R., Paparella M.L., Calb D.E., Bal de Kier Joffe E., Gutkind J.S., Raimondi A.R. Impairing squamous differentiation by Klf4 deletion is sufficient to initiate tongue carcinoma development upon K-Ras activation in mice. Carcinogenesis 2014, 35:662-669.
2. Akaogi K., Nakajima Y., Ito I., Kawasaki S., Oie S.H., Murayama A., Kimura K., Yanagisawa J. KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha. Oncogene 2009, 28:2894-2902.
3. Boj S.F., Hwang C.I., Baker L.A., Chio I.I., Engle D.D., Corbo V., Jager M., Ponz-Sarvise M., Tiriac H., Spector M.S., et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 2015, 160:324-338.
4. Brembeck F.H., Rustgi A.K. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J. Biol. Chem. 2000, 275:28230-28239.
5. Brembeck F.H., Moffett J., Wang T.C., Rustgi A.K. The keratin 19 promoter is potent for cell-specific targeting of genes in transgenic mice. Gastroenterology 2001, 120:1720-1728.
6. Brembeck F.H., Schreiber F.S., Deramaudt T.B., Craig L., Rhoades B., Swain G., Grippo P., Stoffers D.A., Silberg D.G., Rustgi A.K. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res. 2003, 63:2005-2009.
7. Carriere C., Seeley E.S., Goetze T., Longnecker D.S., Korc M. The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. Proc. Natl. Acad. Sci. USA 2007, 104:4437-4442.
8. Cercek A., Wheler J., Murray P.E., Zhou S., Saltz L. Phase 1 study of APTO-253 HCl, an inducer of KLF4, in patients with advanced or metastatic solid tumors. Invest. New Drugs 2015, 33:1086-1092.
9. Deschenes C., Vezina A., Beaulieu J.F., Rivard N. Role of p27(Kip1) in human intestinal cell differentiation. Gastroenterology 2001, 120:423-438.
10. El-Karim E.A., Hagos E.G., Ghaleb A.M., Yu B., Yang V.W. Kruppel-like factor 4 regulates genetic stability in mouse embryonic fibroblasts. Mol. Cancer 2013, 12:89.
11. Faber K., Bullinger L., Ragu C., Garding A., Mertens D., Miller C., Martin D., Walcher D., Dohner K., Dohner H., et al. CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARgamma signaling. J. Clin. Invest. 2013, 123:299-314.
12. Gidekel Friedlander S.Y., Chu G.C., Snyder E.L., Girnius N., Dibelius G., Crowley D., Vasile E., DePinho R.A., Jacks T. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 2009, 16:379-389.
13. Guerra C., Schuhmacher A.J., Canamero M., Grippo P.J., Verdaguer L., Perez-Gallego L., Dubus P., Sandgren E.P., Barbacid M. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007, 11:291-302.
14. Habbe N., Shi G., Meguid R.A., Fendrich V., Esni F., Chen H., Feldmann G., Stoffers D.A., Konieczny S.F., Leach S.D., Maitra A. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc. Natl. Acad. Sci. USA 2008, 105:18913-18918.
15. Hamamoto N., Ashizawa N., Niigaki M., Kaji T., Katsube T., Endoh H., Watanabe M., Sumi S., Kinoshita Y. Morphological changes in the rat exocrine pancreas after pancreatic duct ligation. Histol. Histopathol. 2002, 17:1033-1041.
16. Hezel A.F., Kimmelman A.C., Stanger B.Z., Bardeesy N., Depinho R.A. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006, 20:1218-1249.
17. Hingorani S.R., Petricoin E.F., Maitra A., Rajapakse V., King C., Jacobetz M.A., Ross S., Conrads T.P., Veenstra T.D., Hitt B.A., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003, 4:437-450.
18. Houbracken I., de Waele E., Lardon J., Ling Z., Heimberg H., Rooman I., Bouwens L. Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas. Gastroenterology 2011, 141:731-741. 741.e1-4.
19. Hruban R.H., Wilentz R.E., Maitra A. Identification and analysis of precursors to invasive pancreatic cancer. Methods Mol. Med. 2005, 103:1-13.
20. Huch M., Bonfanti P., Boj S.F., Sato T., Loomans C.J., van de Wetering M., Sojoodi M., Li V.S., Schuijers J., Gracanin A., et al. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. EMBO J. 2013, 32:2708-2721.
21. Ischenko I., Petrenko O., Hayman M.J. Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas. Proc. Natl. Acad. Sci. USA 2014, 111:3466-3471.
22. Jensen J.N., Cameron E., Garay M.V., Starkey T.W., Gianani R., Jensen J. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 2005, 128:728-741.
23. Ji B., Tsou L., Wang H., Gaiser S., Chang D.Z., Daniluk J., Bi Y., Grote T., Longnecker D.S., Logsdon C.D. Ras activity levels control the development of pancreatic diseases. Gastroenterology 2009, 137:1072-1082. 1082.e1-6.
24. Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Kamiyama H., Jimeno A., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806.
25. Kanda M., Matthaei H., Wu J., Hong S.M., Yu J., Borges M., Hruban R.H., Maitra A., Kinzler K., Vogelstein B., Goggins M. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 2012, 142:730-733.e9.
26. Katz J.P., Perreault N., Goldstein B.G., Lee C.S., Labosky P.A., Yang V.W., Kaestner K.H. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002, 129:2619-2628.
27. Katz J.P., Perreault N., Goldstein B.G., Actman L., McNally S.R., Silberg D.G., Furth E.E., Kaestner K.H. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 2005, 128:935-945.
28. Kopp J.L., von Figura G., Mayes E., Liu F.F., Dubois C.L., Morris J.P., Pan F.C., Akiyama H., Wright C.V., Jensen K., et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 2012, 22:737-750.
29. Li J., Zheng H., Yu F., Yu T., Liu C., Huang S., Wang T.C., Ai W. Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis. Carcinogenesis 2012, 33:1239-1246.
30. Li Q., Jia Z., Wang L., Kong X., Li Q., Guo K., Tan D., Le X., Wei D., Huang S., et al. Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. Gastroenterology 2012, 142:531-542.
31. Liao X., Sharma N., Kapadia F., Zhou G., Lu Y., Hong H., Paruchuri K., Mahabeleshwar G.H., Dalmas E., Venteclef N., et al. Kruppel-like factor 4 regulates macrophage polarization. J. Clin. Invest. 2011, 121:2736-2749.
32. Lowenfels A.B., Maisonneuve P., Cavallini G., Ammann R.W., Lankisch P.G., Andersen J.R., Dimagno E.P., Andren-Sandberg A., Domellof L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N. Engl. J. Med. 1993, 328:1433-1437.
33. Maier H.J., Wagner M., Schips T.G., Salem H.H., Baumann B., Wirth T. Requirement of NEMO/IKKgamma for effective expansion of KRAS-induced precancerous lesions in the pancreas. Oncogene 2013, 32:2690-2695.
34. Mazur P.K., Gruner B.M., Nakhai H., Sipos B., Zimber-Strobl U., Strobl L.J., Radtke F., Schmid R.M., Siveke J.T. Identification of epidermal Pdx1 expression discloses different roles of Notch1 and Notch2 in murine Kras(G12D)-induced skin carcinogenesis in vivo. PLoS One 2010, 5:e13578.
35. McAllister F., Bailey J.M., Alsina J., Nirschl C.J., Sharma R., Fan H., Rattigan Y., Roeser J.C., Lankapalli R.H., Zhang H., et al. Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer Cell 2014, 25:621-637.
36. Means A.L., Meszoely I.M., Suzuki K., Miyamoto Y., Rustgi A.K., Coffey R.J., Wright C.V., Stoffers D.A., Leach S.D. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 2005, 132:3767-3776.
37. Morris J.P., Cano D.A., Sekine S., Wang S.C., Hebrok M. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J. Clin. Invest. 2010, 120:508-520.
38. Muir K.R., Lima M.J., Docherty H.M., McGowan N.W., Forbes S., Heremans Y., Forbes S.J., Heimberg H., Casey J., Docherty K. Kruppel-like factor 4 overexpression initiates a mesenchymal-to-epithelial transition and redifferentiation of human pancreatic cells following expansion in long term adherent culture. PLoS One 2015, 10:e0140352.
39. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
40. Prasad N.B., Biankin A.V., Fukushima N., Maitra A., Dhara S., Elkahloun A.G., Hruban R.H., Goggins M., Leach S.D. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res. 2005, 65:1619-1626.
41. Pylayeva-Gupta Y., Lee K.E., Hajdu C.H., Miller G., Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012, 21:836-847.
42. Qian J., Niu J., Li M., Chiao P.J., Tsao M.S. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Cancer Res. 2005, 65:5045-5053.
43. Ray K.C., Bell K.M., Yan J., Gu G., Chung C.H., Washington M.K., Means A.L. Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model. PLoS One 2011, 6:e16786.
44. Rowland B.D., Bernards R., Peeper D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 2005, 7:1074-1082.
45. Sawey E.T., Johnson J.A., Crawford H.C. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc. Natl. Acad. Sci. USA 2007, 104:19327-19332.
46. Segre J.A., Bauer C., Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 1999, 22:356-360.
47. Shi M., Cui J., Du J., Wei D., Jia Z., Zhang J., Zhu Z., Gao Y., Xie K. A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer. Clin. Cancer Res. 2014, 20:4370-4380.
48. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J. Clin. 2015, 65:5-29.
49. Siveke J.T., Lubeseder-Martellato C., Lee M., Mazur P.K., Nakhai H., Radtke F., Schmid R.M. Notch signaling is required for exocrine regeneration after acute pancreatitis. Gastroenterology 2008, 134:544-555.
50. Stanger B.Z., Stiles B., Lauwers G.Y., Bardeesy N., Mendoza M., Wang Y., Greenwood A., Cheng K.H., McLaughlin M., Brown D., et al. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 2005, 8:185-195.
51. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
52. Talmasov D., Xinjun Z., Yu B., Nandan M.O., Bialkowska A.B., Elkarim E., Kuruvilla J., Yang V.W., Ghaleb A.M. Kruppel-like factor 4 is a radioprotective factor for the intestine following gamma-radiation-induced gut injury in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2015, 308:G121-G138.
53. Tetreault M.P., Wang M.L., Yang Y., Travis J., Yu Q.C., Klein-Szanto A.J., Katz J.P. Klf4 overexpression activates epithelial cytokines and inflammation-mediated esophageal squamous cell cancer in mice. Gastroenterology 2010, 139:2124-2134.e9.
54. Tetreault M.P., Yang Y., Travis J., Yu Q.C., Klein-Szanto A., Tobias J.W., Katz J.P. Esophageal squamous cell dysplasia and delayed differentiation with deletion of Kruppel-like factor 4 in murine esophagus. Gastroenterology 2010, 139:171-181.e9.
55. von Figura G., Fukuda A., Roy N., Liku M.E., Morris Iv J.P., Kim G.E., Russ H.A., Firpo M.A., Mulvihill S.J., Dawson D.W., et al. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat. Cell Biol. 2014, 16:255-267.
56. Wei D., Gong W., Kanai M., Schlunk C., Wang L., Yao J.C., Wu T.T., Huang S., Xie K. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005, 65:2746-2754.
57. Wei D., Kanai M., Huang S., Xie K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 2006, 27:23-31.
58. Wei D., Kanai M., Jia Z., Le X., Xie K. Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res. 2008, 68:4631-4639.
59. Wei D., Wang L., Kanai M., Jia Z., Le X., Li Q., Wang H., Xie K. KLF4alpha up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology 2010, 139:2135-2145.
60. Wu C.Y., Carpenter E.S., Takeuchi K.K., Halbrook C.J., Peverley L.V., Bien H., Hall J.C., DelGiorno K.E., Pal D., Song Y., et al. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice. Gastroenterology 2014, 147:1405-1416.e7.
61. Yu T., Chen X., Zhang W., Liu J., Avdiushko R., Napier D.L., Liu A.X., Neltner J.M., Wang C., Cohen D., et al. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ. 2016, 23:207-215.